Clinical relevance and plasmid dynamics of mcr-1-positive Escherichia coli in China: a multicentre case-control and molecular epidemiological study
Clinical relevance and plasmid dynamics of mcr-1-positive Escherichia coli in China: a multicentre case-control and molecular epidemiological study
复制标题
中国 mcr-1 阳性大肠杆菌的临床相关性和质粒动态:多中心病例对照和分子流行病学研究
DOI:
10.1016/s2666-5247(20)30001-x
复制
发表时间:
2020-05-01
期刊:
影响因子:
38.2
通讯作者:
Yu, Yunsong
中科院分区:
文献类型:
--
作者:
Jiang, Yan;Zhang, Ying;Yu, Yunsong
Background Although the emergence of the plasmid-mediated colistin resistance gene, mcr-1, caused global concern, little is known about its clinical implications and transmission characteristics over time. We aimed to investigate the clinical relevance of infection with mcr-1-positive Escherichia coli isolates and to investigate long-term plasmid dynamics.Methods We did a multicentre case-control study and molecular epidemiological survey of mcr-1-positive E coli infections. E coli isolates from four hospitals in China in 2008 to 2017 were collected and screened for mcr-1 by PCR and Sanger sequencing. Patients with mcr-1-positive E coli infections and matched controls with mcr-1-negative E coli infections were included in a 1:4 ratio, considering age, sex, living environment, comorbidities, antimicrobials used, and clinical sample type as potential risk factors in a regression model. 28-day mortality was also observed. The genomes of all mcr-1-positive E coli were sequenced to explore their genetic background and map ISApl1 elements. Plasmids carrying mcr-1 were characterised by their resistance profile and incompatibility group.Findings 29 100 isolates were collected across all hospitals and during the study period, 300 (1.03%) of which were mcr-1-positive E coli. The overall proportion of mcr-1-positive isolates significantly increased from 0.42% (1 of 240) in 2008 to 1.39% (66 of 4748; p